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C. elegans PAT-6/Actopaxin Plays a Critical Role
in the Assembly of Integrin Adhesion
Complexes In Vivo
functions, including the relatively recent discovery that
signaling proteins present in focal adhesion complexes
control many basic cellular functions including cell mo-
tility, proliferation, and gene expression in response to
ECM binding [2].
Xinyi Lin,1 Hiroshi Qadota,2 Donald G. Moerman,2
and Benjamin D. Williams1,*
1Department of Cell and Structural Biology
University of Illinois at Urbana-Champaign
601 South Goodwin Avenue
Urbana, Illinois 61801 The body wall muscle attachments of C. elegans are
in vivo homologs of focal adhesions [3–10] and provide2 Department of Zoology
University of British Columbia an opportunity to genetically dissect the assembly and
function of this important class of integrin-mediated at-Vancouver, British Columbia
Canada V6T 1Z4 tachments in vivo. Previously, we used forward genetic
screens to identify genes required to form C. elegans
muscle attachments [11]. The subsequent molecular
isolation of several of these genes [5–7, 12] has con-Summary
firmed that they encode muscle attachment proteins
(summarized in Figure 1 of [12]). Removing these pro-Background: The novel focal adhesion protein acto-
teins individually through protein null mutations causespaxin includes tandem unconventional calponin homol-
reproducible, protein-specific defects in attachment as-ogy (CH) domains and a less well-conserved N-terminal
sembly [4–9, 11–14]. These results are summarized asstretch. Dominant-negative studies have implicated ac-
“assembly dependence” pathways in Figure 1. In brieftopaxin in focal adhesion formation.
overview, attachment assembly starts with the “polar-Results: PAT-6/actopaxin, the sole actopaxin homolog
ization” of the attachment proteins to the basal mem-in C. elegans, is located in body wall muscle attachments
brane of the muscle cell. Integrin heterodimers clusterthat are in vivo homologs of focal adhesions. We show
into small foci. These nascent attachments form withinusing pat-6 protein null alleles that PAT-6/actopaxin has
four longitudinal bands, one for each body wall musclecritical nonredundant roles during attachment matura-
quadrant. Initially, the integrin foci have an isotropiction. It is required to recruit UNC-89 and myofilaments
arrangement within each band. During subsequent at-to newly forming attachments, and also to reposition
tachment maturation, however, a highly ordered patternthe attachments so that they form the highly ordered
of readily distinguishable dense bodies and M linesarray of dense body and M line attachments that are
emerges. Attachment maturation also includes the re-characteristic of mature muscle cells. PAT-6/actopaxin
cruitment of cytoplasmic components, which proceedsis not required for the deposition of UNC-52/perlecan
in a membrane-proximal to membrane-distal fashion.in the basal lamina, nor for the initiation of attachment
During the final stages of attachment structure assem-assembly, including the clustering of integrin into foci
bly, myosin and actin filaments associate with the at-and the recruitment of attachment proteins PAT-4/ILK,
tachment complexes, becoming organized into the AUNC-112, and DEB-1/vinculin from the cytosol. PAT-6/
bands and I bands, respectively, of the new contractileactopaxin, PAT-4/ILK, and UNC-112 are each required
units.for the same steps during attachment assembly in vivo,
Previously we have shown that PAT-4/ILK [12] and itsconsistent with the notion that they work together in
binding partner, the novel FERM domain protein UNC-multiprotein complex. Supporting this idea, PAT-4/ILK
112 [5], are both required for the proper assembly ofcan simultaneously bind to PAT-6/actopaxin and UNC-
muscle attachments. In the absence of either UNC-112112, forming a ternary complex, in yeast three-hybrid
or PAT-4/ILK, integrin foci are formed in the basal sarco-assays. Finally, we show that both calponin homology
lemma, but further maturation of these attachments isdomains are required for PAT-6/actopaxin’s critical
blocked. Here we report our investigation of pat-6, an-functions during attachment assembly in vivo.
other gene discovered in our original forward geneticConclusions: We show directly by loss-of-function ge-
screens [11]. We show that pat-6 encodes the sole C.netics that PAT-6/actopaxin plays essential roles during
elegans ortholog of the recently discovered focal adhe-the maturation of integrin-mediated muscle attach-
sion protein actopaxin/parvin/CH-ILKBP/affixin [15–18].ments in vivo.
Several distinct members of the vertebrate actopaxin
family were recently discovered though yeast two-
Introduction hybrid screens for interactors of paxillin [15] or ILK [17,
18], and also through database searches for novel mem-
Focal adhesions are transmembrane linkages between bers of the -actinin superfamily of actin binding pro-
the extracellular matrix and the cell’s actin cytoskeleton teins [16]. To date, the vertebrate actopaxin family in-
mediated by the transmembrane protein integrin. In re- cludes three distinct isoforms: the founding member
sponse to ECM binding by the integrin extracellular do- is actopaxin/-parvin/CH-ILKBP [15–17], a very closely
main, the cytoplasmic domain initiates the assembly of related second isoform is -parvin/affixin [16, 18], and
a multiprotein adhesion complex [1]. Focal adhesions a more distantly related isoform is -parvin [16]. The
have played a central role in investigations of integrin’s actopaxin family is characterized by a pair of 100
amino acid unconventional calponin homology (CH) do-
mains arranged in tandem and separated by a 60*Correspondence: bdwillms@uiuc.edu
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Figure 1. Assembly Dependence Pathways
for Dense Bodies and M Lines
UNC-52/perlecan begins the related path-
ways for dense bodies (A) and M lines (B).
When UNC-52/perlecan is removed by muta-
tion, integrin fails to polarize to the basal sar-
colemma, integrin foci are not formed, the
cytoplasmic dense body and M line proteins
are not recruited from the cytosol, and neither
actin thin filaments nor myosin thick filaments
are recruited properly into the I and A bands
of contractile units [13]. PAT-3/integrin is
downstream from UNC-52/perlecan in both
the dense body and M line pathways because
the removal of integrin has no effect on the
initial deposition of UNC-52/perlecan in the
basal lamina, but it does block the recruit-
ment of all cytoplasmic attachment complex
components, as well as I and A band forma-
tion [13]. The dense body and M line path
ways differ downstream from integrin. The dense body pathway splits into two parallel branches at this point. One branch continues with
DEB-1/vinculin and the other with UNC-112, PAT-4/ILK, and PAT-6/actopaxin. Proteins placed in separate branches are recruited independently
to dense bodies. UNC-112 [5], PAT-4/ILK [12], and PAT-6/actopaxin (see Results) are recruited to nascent attachments in deb-1 mutants that
lack vinculin. Conversely, DEB-1/vinculin enters nascent attachments formed in unc-112 [6], pat-4 [12], and pat-6 protein null mutants (see
Results), although in pat-4 mutants, the recruitment of DEB-1/vinculin appears to be less robust than in the other mutants. UNC-112 and
PAT-4/ILK are placed at the same level of the pathway because they are mutually dependent on each other to be recruited to muscle
attachments [12]. Data presented in this paper place PAT-6/actopaxin downstream from UNC-112 and PAT-4/ILK. There are currently insufficient
data to position talin [8] and UNC-97/PINCH [9] definitively within either the dense body or M line pathways, so these proteins are listed within
an open bracket to the right. The parallel branches within the dense body pathway converge before the recruitment of actin filaments into I
bands because this final step requires both branches. -actinin is a membrane-distal component of larval and adult dense bodies [10] and
is not included here because it is apparently added to already functional dense bodies sometime after hatching. Downstream from PAT-3/
integrin, the M line pathway closely resembles the PAT-4/ILK branch of the dense body pathway. There is no DEB-1/vinculin branch in the
M line pathway because this protein is not present in M lines [3, 10]. The M line pathway is unique downstream from PAT-6/actopaxin. It
continues with UNC-89, a membrane-distal protein specific to M lines [4], and then ends with recruitment of myosin thick filaments into A
bands.
amino acid linker. Tandem CH domains often serve as 2A). The hypothetical gene T21D12.4, identified by the
an actin binding domain in structural proteins [19], and C. elegans genome sequencing consortium near the
actopaxin/-parvin/CH-ILKBP binds to actin filaments right end of chromosome IV, is predicted to encode a
in vitro [15, 16]. The CH2 domains of both actopaxin/ protein with significant similarity to the recently identi-
-parvin/CH-ILKBP [17, 20] and -parvin/affixin [18] fied actopaxin family of focal adhesion proteins (65%
bind to integrin-linked kinase (ILK). The CH2 domain of similarity, 48% identity when compared to actopaxin/
actopaxin/-parvin/CH-ILKBP also binds to paxillin [15, -parvin/CH-ILKBP). We performed standard RNA inter-
20]. There have been some conflicting results reported ference (RNAi) experiments as a first test of this candi-
regarding paxillin binding by actopaxin/-parvin/CH- date. Wild-type hermaphrodites injected with T21D12.4
ILKBP [15, 17, 21]. Consequently, there are different double-stranded RNA produced 100% Pat progeny (n
interpretations as to the roles of paxillin and ILK binding 300), consistent with the possibility that T21D12.4 corre-
during the recruitment of actopaxin/-parvin/CH-ILKBP sponds to pat-6. To directly test this hypothesis, we
to focal adhesions. The transgenic expression of mutant made transgenic extrachromsomal arrays carrying
forms of several actopaxin family members can delay T21D12.4 and 2.5 kb of upstream noncoding genomic
focal adhesion assembly [15, 17, 18], suggesting that DNA. Each of the independently generated arrays (n 3)
actopaxin plays an important role in this process. To completely rescues the developmental arrest phenotype
date, there has been no direct genetic analysis of acto- of pat-6 mutants, allowing us to establish viable, trans-
paxin function in vivo. genically rescued strains homozygous for a pat-6 loss-
Here we report a detailed genetic analysis of PAT-6/ of-function mutation (see below). These results directly
actopaxin’s role during muscle attachment assembly in confirm the molecular identity of pat-6. We refer to the
C. elegans. Our data show that PAT-6/actopaxin plays a pat-6 protein as PAT-6/actopaxin.
critical role during the maturation of muscle attachments Complete DNA sequence analysis of two independent
and places it within the assembly dependence pathway full-length pat-6 cDNAs confirms the mRNA structure
shown in Figure 1. originally predicted by the Genefinder program for
T21D12.4 (Figure 2A). Neither cDNA showed any evi-
dence of alternative splicing.Results
To identify the pat-6 mutations at the molecular level,
we sequenced all of the pat-6 exons and RNA splicepat-6 Encodes the Sole C. elegans Homolog
junctions from the two independent pat-6 mutants,of Actopaxin
st561 and st570. Each contains a different point muta-We combined positional cloning and candidate gene
approaches to molecularly isolate the pat-6 gene (Figure tion creating a premature nonsense codon within the
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Figure 2. The pat-6 Gene Encodes the C. ele-
gans Actopaxin Ortholog
(A) Molecular cloning of pat-6 (see Results
for details).
(B) Immunoblot of whole-worm protein ex-
tracts prepared from the wild-type N2 strain
(lane 1) or a pat-6(st561) mutant strain that is
rescued by a pat-6::gfp transgene (lane 2).
The blot was probed with anti-PAT-6/acto-
paxin.
(C) PAT-6::GFP expressed by a rescued430
min postfertilization pat-6(st561) embryo is
localized to body wall muscle attachments
(arrows).
(D) Same embryo as in (C) immunostained
with anti-PAT-6/actopaxin and MH27. As ex-
pected, muscle attachments stain with anti-
PAT-6 (arrows).
(E) Merge of (C) and (D), yellow regions show
colocalization of the PAT-6::GFP and anti-
PAT-6/actopaxin signals.
(F) A nonrescued pat-6(st561) embryo at the
same developmental stage has no GFP
signal.
(G) Same embryo as in (F) immunostained
with anti-PAT-6/actopaxin and MH27. No
PAT-6/actopaxin is detected in the region con-
taining a dorsal muscle quadrant (arrows). Hy-
podermal cell junctions (arrowheads) and hy-
podermal cell junction remnants (labeled “j”)
are stained by antibody MH27.
(H) Merge of (F) and (G). Scale bar, 5 m.
protein-coding region (Figure 2A). To test whether these hypodermal syncytium. To show that the pat-6 mutants
contain no detectable PAT-6/actopaxin, we repeatedmutations block PAT-6/actopaxin expression, we raised
an antiserum against the PAT-6/actopaxin N terminus. the immunostaining experiments without the MH27 anti-
body. We identified pat-6 mutant homozygotes by theirThe anti-PAT-6/actopaxin antibody stains body wall
muscle cell attachments of wild-type (not shown) and abnormal 2-fold arrested morphology. All of these em-
bryos (n  200) were completely negative for antibodypat-6 embryos that have been rescued by a functional
pat-6::Green Fluorescent Protein (GFP) transgene. In the staining.
We further investigated the specificity of the anti-rescued embryos, the GFP (Figure 2C) and the anti-
PAT-6 (Figure 2D, arrows) signals colocalize at body wall PAT-6/actopaxin antibody on Western blots of whole-
worm protein prepared from mixed populations of C.muscle attachments (yellow regions in merged image,
Figure 2E). The monoclonal antibody MH27 stains hypo- elegans adults and larvae. As expected, anti-PAT-6 de-
tects a single45 kDa polypeptide in wild-type N2 straindermal cell junctions (arrowheads, Figures 2D and 2G)
and serves as a positive control for antibody penetra- blots (Figure 2B, lane 1). In identical blots prepared from
a pat-6 mutant strain that is rescued with a pat-6::gfption. Nonrescued pat-6 embryos do not express GFP
(Figure 2F) and do not stain with the anti-PAT-6 antibody transgene, anti-PAT-6 detects a single 66 kDa band
that is consistent with the predicted molecular weight(Figure 2G, arrows indicate location of the nonstained
dorsal body wall muscle cells), but the MH27 staining of PAT-6::GFP (Figure 2B, lane 2).
pattern is intact (Figure 2G, arrowheads), confirming an-
tibody penetration. The remnants of several hypodermal PAT-6/Actopaxin Colocalizes with Integrin
and PAT-4/ILK at Muscle Attachmentscell junctions are visible in the region of the dorsal mus-
cle quadrant (labeled “j,” Figure 2G). These junctions We investigated PAT-6/actopaxin expression in em-
bryos, larvae, and adults using the anti-PAT-6/actopaxinare lost during the formation of hyp7, which is a large
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moved into a regular striated array, and distinguishable
dense body and M lines are not yet visible.
To directly confirm that PAT-6/actopaxin colocalizes
with integrin and with PAT-4/ILK within the nascent mus-
cle attachments, we stained the pat-6::gfp-rescued em-
bryos with either an antibody to PAT-3, the only integrin
 subunit expressed in body wall muscles [7], or to
PAT-4/ILK [12]. We also included the MH27 antibody
to visualize hypodermal cell adherens junctions. PAT-
6::GFP colocalizes with PAT-3/integrin (Figures 3A–3C)
and with PAT-4/ILK (Figures 3D–3F) at body-wall muscle
attachments (arrows, Figures 3A–3F).
PAT-6::GFP continues to colocalize with integrin at
the body wall muscle attachments during the remaining
stages of embryogenesis, larval development, and
adulthood. Figure 3G shows PAT-6::GFP in adult dense
bodies (arrows), M lines (arrowheads), and muscle-mus-
cle adhesion plaques (between brackets). Functional
PAT-6/actopaxin::Cyan Fluorescent Protein (CFP) (Fig-
ure 3H) and PAT-3/integrin::Yellow Fluorescent Protein
(YFP) (Figure 3I) fusion proteins expressed from a trans-
genic extrachomosomal array colocalize extensively in
adult muscle attachments (white regions in merged im-
age, Figure 3J).
In adult hermaphrodites, PAT-6::GFP is also located in
the attachments of other muscles, including the uterine,
anal depressor, anal sphincter, and vulval muscles, as
well as in the spermatheca and the distal tip cells (data
not shown). PAT-6::GFP is also located in the cell bodies
and axonal processes of the mechanosensory receptor
neurons ALML/R, PLML/R, AVM, and PVM (data not
shown). These are all expected results because each of
these structures also contains PAT-3/integrin  subunit
[7], PAT-4/ILK [12], and UNC-97/PINCH [9].
PAT-6 Is Required for Dense BodyFigure 3. PAT-6::GFP Colocalizes with PAT-3/Integrin and PAT-4/
and M Line AssemblyILK in Muscle Attachments
We have shown previously that actin and myosin fila-(A–C) pat-6 embryo rescued by PAT-6::GFP and stained with the
ments are not recruited properly into I bands or A bands,anti-PAT-3/integrin antibody MH25. (A) GFP channel, (B) anti-PAT-3/
integrin channel, (C) merge. PAT-6::GFP and PAT-3/integrin colocal- respectively, in pat-6 mutants [11], suggesting that the
ize (C, yellow regions) in embryonic muscle attachments (arrows). assembly of muscle attachments has been disrupted.
(D–F) pat-6 embryo rescued by PAT-6::GFP and stained with the To investigate PAT-6/actopaxin function in detail, we
anti-PAT-4/ILK. (D) GFP, (E) anti-PAT-4/ILK, (F) merge. PAT-6::GFP
performed two series of genetic experiments to accu-and PAT-4/ILK colocalize (E, yellow regions) in embryonic muscle
rately position PAT-6/actopaxin within the assembly de-attachments (arrows).
pendence pathways shown in Figure 1.(G) PAT-6::GFP is located in adult body wall muscle attachments.
Dense bodies (arrows), M lines (arrowheads), and muscle-muscle In the first series of experiments, we investigated the
adhesion plaques (brackets) are indicated. effects of the removal of PAT-6/actopaxin on the recruit-
(H–J) Body wall muscle attachments of an adult that is coexpressing ment of other muscle attachment proteins (Figure 4A).
PAT-6::CFP and PAT-3::YFP. (H) CFP channel, (I) YFP channel, (J)
The ECM protein UNC-52/perlecan, at the top of themerge. White areas in (J) show extensive colocalization of PAT-
assembly dependence pathway, is organized normally6::CFP and PAT-3::YFP in muscle attachments. All scale bars, 5 m.
in pat-6(st561) mutants, as can be seen by comparing
wild-type (Figure 4A1) and pat-6(st561) (Figure 4A1)
530 min embryos. In both the wild-type and pat-6antiserum and the functional pat-6::gfp transgene.
PAT-6/actopaxin is first detectable in the myoblasts of embryos, UNC-52/perlecan is located in a continuous
stripe within the basal lamina that subtends the bodyearly embryos, where it is distributed throughout the
cytoplasm (data not shown). When the embryos reach wall muscle cells. Integrin, which is just downstream
from UNC-52/perlecan within the assembly dependencethe 1.5-fold stage of development (430 min postfertil-
ization), most of the PAT-6/actopaxin is polarized within pathway, polarizes to the basal sarcolemma and enters
into nascent attachment complexes in both wild-typethe muscle cells and has entered nascent attachments
(Figure 3A, arrows). In each body wall muscle quadrant, and pat-6 mutants. In wild-type embryos, PAT-3/integrin
is located in an ordered array of recognizable densePAT-6/actopaxin appears as a single longitudinal stripe
of tightly clustered foci. These attachments have not yet bodies and M lines (arrows, Figure 4A2). In contrast,
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Figure 4. Epistasis Analysis of Muscle Attachment Assembly
(A) Localization of UNC-52/perlecan, PAT-3/-integrin, UNC-112, PAT-4/ILK, DEB-1/vinculin, and UNC-89 in wild-type (1–6) and pat-6(st561)
(1–6) in 530 min embryos. Arrows in all panels except for 6 indicate body wall muscle attachments. Arrows in 6 indicate clumps of UNC-
89 protein located in the cytoplasm of body wall muscle cells. All proteins visualized by antibody staining except for UNC-112, which was
visualized using a functional unc-112::gfp transgene.
(B) Localization of PAT-6/actopaxin in wild-type, unc-52(st549), pat-3(st552), unc-112(gk1), pat-4(st551), and deb-1(st555) embryos (1–6).
Arrows indicate regions of anti-PAT-6/actopaxin staining. PAT-6/actopaxin is properly recruited to muscle attachments in the wild-type (1)
and deb-1 (6) embryos, but not in the unc-52(st549), pat-3(st552), unc-112(gk1), or pat-4(st551) embryos (2–5). The embryos were also stained
with monoclonal antibody MH27 to hypodermal cell junctions, which appear as a grid-like pattern and are indicated by arrowheads in panel
5. Scale bar (A1), 5 m.
in pat-6 mutant embryos, although PAT-3/integrin has ing, UNC-112, PAT-4/ILK, and DEB-1/vinculin organiza-
tion does not improve any further in the pat-6 mutantsformed nascent attachments, they are not arranged in
a well-organized spatial array (arrow, Figure 4A2). Integ- and begins to deteriorate following the premature arrest
of embryonic elongation (not shown). Finally, we investi-rin’s organization never improves in the pat-6 mutants
and begins to deteriorate after embryonic elongation gated the membrane-distal attachment protein UNC-
89, which is specific to M lines. In wild-type 530 minarrests (not shown).
We next investigated the cytoplasmic attachment pro- embryos, UNC-89 is present in nascent M lines (arrows,
Figure 4A6). In contrast, in the pat-6 mutants, UNC-89teins UNC-112, PAT-4/ILK, and DEB-1/vinculin. Each of
these proteins polarizes and enters nascent attach- neither polarizes nor enters nascent attachment com-
plexes, but instead it forms a large disorganized clumpments in both wild-type (Figures 4A3–4A5) and pat-6
(Figure 4A3 - 4A5)530 min embryos. As we observed within the cytoplasm of each body wall muscle cell
(arrows, Figure 4A6).for PAT-3/integrin, in the wild-type embryos, these pro-
teins are located in nascent attachments that are begin- We conclude from this first series of experiments that
PAT-6/actopaxin is not required for the initial depositionning to resolve into a regular pattern of dense bodies
and M lines (small arrows, Figures 4A3–4A5). In contrast, of UNC-52/perlecan into the basal lamina, nor for the
recruitment of PAT-3/integrin, UNC-112, PAT-4/ILK, orin the pat-6 mutant animals, they are located in nascent
attachments that are not as well organized (arrows, Fig- DEB-1/vinculin into attachment complexes. PAT-6/acto-
paxin is required to recruit the M line protein UNC-89,ures 4A3–4A5). Just as we observed by integrin stain-
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and also for nascent attachments to become properly and sufficient for the binding interaction. Interestingly,
a putative kinase dead PAT-4/ILK containing the E359Korganized into a well-ordered array.
In the second series of experiments, we removed sev- substitution also interacts with PAT-6/actopaxin (Figure
5B, bottom), suggesting that binding between PAT-4/eral different individual attachment proteins by mutation
and investigated the effects on PAT-6/actopaxin local- ILK and PAT-6/actopaxin does not require PAT-4/ILK
kinase activity.ization. In wild-type 500 min embryos, PAT-6/acto-
paxin is polarized and located in nascent attachment
complexes within the basal sarcolemma (arrow, Figure PAT-4/ILK Can Bind Simultaneously
4B1). In contrast, when we remove UNC-52/perlecan, to UNC-112 and PAT-6/Actopaxin
PAT-3/integrin, UNC-112, or PAT-4/ILK, the recruitment in Yeast Three-Hybrid Assays
of PAT-6/actopaxin to muscle attachments is disrupted. The kinase domain of PAT-4/ILK can also bind to UNC-
In the unc-52, pat-3, and unc-112 mutants, PAT-6/acto- 112 [12]. Consequently, we wanted to determine
paxin is located in small puncta within the muscle cell whether PAT-4/ILK can simultaneously bind to PAT-6/
cytoplasm (small arrows, Figures 4B2–4B4). A cell nu- ILK and UNC-112 in yeast three-hybrid assays (Figure
cleus (labeled “n”) occasionally appears as a round, 5C). A PAT-6/actopaxin::GAL4 activator domain fusion
nonstained region in the center of a body wall muscle fails to interact with UNC-112::GAL4 DNA binding do-
cell in these embryos. Interestingly, we are not able to main fusion in standard two-hybrid assays. Swapping
detect any PAT-6/actopaxin in pat-4 mutants (n  200) the activator and DNA binding domains between UNC-
(Figure 4B5). MH27 stains the hypodermal cell junctions 112 and PAT-6/actopaxin also produces no interaction.
(arrowheads) of these animals, however, confirming an- However, in either case, when we introduce a third plas-
tibody penetration. We also had difficulty in detecting mid expressing PAT-4/ILK, we obtain a strong activation
PAT-6/actopaxin in unc-112 mutants (Figure 4B4), while that is completely dependent upon the expression of
this was not the case for the unc-52, pat-3, or deb-1 PAT-4/ILK. Thus, we conclude that PAT-4/ILK can bind
mutants that we stained in parallel. Finally, in contrast to PAT-6/actopaxin and UNC-112 simultaneously.
to each of the other muscle attachment proteins, when
we remove the dense body-specific protein DEB-1/vin-
Function Analysis of PAT-6/Actopaxin Subdomainsculin by mutation, PAT-6/actopaxin is recruited to na-
To investigate PAT-6/actopaxin subdomain function, wescent muscle attachments (arrow, Figure 4B6). We con-
used standard transgenic extrachromosomal arrays toclude from this second series of experiments that the
express various mutant forms of PAT-6::YFP in vivo. Weproper polarization and recruitment of PAT-6/actopaxin
performed two fundamentally different kinds of func-to muscle attachments requires UNC-52/perlecan, PAT-3/
tional assays. For “recruitment” assays, we used ani-integrin, UNC-112, and PAT-4/ILK, but does not require
mals that also express the endogenous wild-type PAT-6/DEB-1/vinculin.
actopaxin. These assays are comparable to focal ad-Combining the results from both sets of experiments,
hesion recruitment assays that have been performedwe draw several conclusions that are summarized in
previously in cultured mammalian cells [15–18, 20]. InFigure 1. First, PAT-6/actopaxin functions downstream
contrast, for “rescue” assays, we introduced the samefrom UNC-52, PAT-3/integrin, UNC-112, and PAT-4/ILK
transgenic constructs into pat-6(st561) mutant homozy-in both the dense body and M line assembly dependence
gotes and determined whether these constructs rescuepathways. Second, PAT-6/actopaxin functions up-
the Pat phenotype, producing a viable transgenic strain.stream from UNC-89 within the M line pathway. Third,
Mutant forms of PAT-6::YFP lacking the unique N-ter-PAT-6/actopaxin and DEB-1/vinculin are recruited inde-
minal stretch, the CH1 domain, or both the N-terminalpendently to dense bodies, which we indicate in Figure
stretch and CH1 are recruited efficiently to muscle at-1 by drawing two parallel branches within the assembly
tachments (Figures 6B, 6D, and 6F). In contrast, PAT-dependence pathway. These two branches converge
6::YFP lacking the CH2 domain is not recruited efficientlyagain at the bottom of the pathway because DEB-1/
to muscle attachments, and instead is detectable in thevinculin [14], UNC-112, PAT-4/ILK, and PAT-6/actopaxin
cytoplasm (Figure 6C). We conclude that CH2 is bothare all required for the proper recruitment of actin fila-
necessary and sufficient for the recruitment of PAT-6/ments into I bands [11].
actopaxin to muscle attachments, consistent with pre-
viously reported mammalian focal adhesion recruitment
assays [15–18, 20].PAT-4/ILK and PAT-6/Actopaxin Bind to Each
Other in Yeast Two-Hybrid Assays It is noteworthy that the muscle attachments appear
normal in each of the C. elegans strains that we con-Since vertebrate actopaxin family members bind to ILK
[17, 18, 20], we wanted to confirm that PAT-6/actopaxin structed for these recruitment experiments. We found
no evidence of dominant-negative effects that areand PAT-4/ILK interact in yeast two-hybrid assays. PAT-
6/actopaxin interacts strongly with PAT-4/ILK (Figures caused by the transgenic expression of mutant forms
of PAT-6/actopaxin.5A and 5B), but not with UNC-112, UNC-97/PINCH, or
the cytoplasmic domain of the PAT-3/integrin  subunit We next performed rescue assays using each of the
mutant forms of PAT-6/actopaxin. PAT-6/actopaxin(data not shown). We mapped the interacting sites to the
second CH domain of PAT-6/actopaxin and the kinase lacking the unique N-terminal stretch fully rescues pat-
6(st561) mutants (Figure 6F). In contrast, neither CH1-domain of PAT-4/ILK (Figures 5A and 5B), as has been
shown previously for mammalian actopaxin family mem- nor CH2-deleted PAT-6::YFP can rescue pat-6(st561)
mutants (Figures 6B and 6C). We conclude that bothbers [16–18, 20]. These domains are both necessary
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Figure 5. Yeast Two- and Three-Hybrid Analyses of PAT-6/Actopaxin Binding Interactions
(A) Interactions between various regions of PAT-6/actopaxin (open boxes) and full-length PAT-4/ILK. The plus and minus symbols provide an
indication of how well the yeast grew. The strip on the right shows three replicate yeast clones grown on selective media.
(B) Interactions between various regions of the PAT-4/ILK protein (open boxes) and full-length PAT-6/actopaxin.
(C) PAT-4/ILK can bind simultaneously to UNC-112 and PAT-6/actopaxin in yeast three-hybrid assays. Table summarizing yeast strains and
results.  indicates growth, 	 indicates no growth (top). Photograph of a yeast plate showing the degree of growth of each strain (bottom).
CH domains are required to rescue the lethal phenotype functional deficits associated with the F275D mutant
form of PAT-6/actopaxin.of pat-6(st561) homozygotes, while the N-terminal
stretch of PAT-6/actopaxin is dispensable for rescue. We showed above that CH1-deleted PAT-6/actopaxin
is recruited to muscle attachments in a wild-type back-The F271D mutation within CH2 of vertebrate acto-
paxin/-parvin/CH-ILKBP has been reported to block ground but fails to rescue pat-6(st561) mutants (Figure
6B). It is possible that CH1-deleted PAT-6/actopaxin,both binding to ILK and recruitment to focal adhesions
[17]. A second group confirms the diminished recruit- though unable to provide full rescue, may partially res-
cue the assembly of muscle attachments. For example,ment of F271D actopaxin/-parvin/CH-ILKBP to focal
adhesions, but finds no deficit in ILK binding [20]. We it might rescue the patterning of the nascent attach-
ments, or perhaps, the recruitment of potential PAT-6/tested the comparable F275D PAT-6/actopaxin in two-
hybrid, recruitment, and rescue assays. F275D PAT-6/ actopaxin binding partners located downstream in ei-
ther the dense body or the M line assembly dependenceactopaxin binds PAT-4/ILK in yeast two-hybrid assays
(data not shown), is recruited efficiently to muscle at- pathways shown in Figure 1. To investigate these possi-
bilities, we analyzed the body wall muscle attachmentstachments, and can rescue pat-6(st561) homozygotes
(Figure 6E). Thus, we have not been able to identify any made by pat-6(st561) embryos expressing CH1-deleted
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Figure 6. Functional Analysis of PAT-6/Acto-
paxin Subdomains In Vivo
Constructs (left column), the results of re-
cruitment assays (middle column), and the
results of rescue assays (right column) are
shown. For each recruitment assay, a micro-
graph shows localization of YFP-tagged wild-
type or mutant PAT-6/actopaxin within adult
body wall muscle cells. For the recruitment
assays, () indicates efficient localization
of the YPP-tagged protein to dense bodies
and M lines, while () indicates inefficient lo-
calization that is correlated with significant
levels of the mutant protein within the muscle
cell cytoplasm. For all rescue assays, () indi-
cates rescue of pat-6(st6561) mutants as
shown by recovery of viable transgenic
strains, and (	) indicates no rescue. Scale
bar (A), 5 m.
PAT-6::YFP from a transgenic extrachromosomal array. along the anterior-posterior axis of each muscle cell
(Figures 7D and 7H). Similarly, anti-F actin staining re-We stained these embryos with antibodies to UNC-89
(Figure 7B), myosin A (Figure7D), and F-actin (Figure veals a few irregular, fibrous aggregates of actin fila-
ments per muscle cell. These abnormal aggregates of7F), in every case also directly confirming expression of
CH1-deleted PAT-6::YPF in the YFP channel (Figures myosin and actin filaments do not appear to be closely
associated with the basal sarcolemma, although this is7A, 7C, and 7E). We identified the530 min pat-6(st561)
homozygotes by their abnormally shaped hypodermal difficult to determine definitively because the body wall
muscle cells are very thin. In contrast, in wild-type em-cells, which is a characteristic of Pat embryos after elon-
gation has arrested. CH1-deleted PAT-6::YPF localizes bryos of similar age, myosin and actin filaments are
recruited into several well organized A and I bands (Fig-to muscle attachments, but it does not rescue their spa-
tial pattern patterning (arrow, Figure 7A), which is not ures 7G and 7I, respectively) at the basal sarcolemma
of each muscle cell. Because each muscle quadrant isimproved relative to attachment patterning in pat-
6(st561) embryos that do not carry any transgene (arrow, two muscle cells wide, four A bands (Figure 7G, arrow)
and the equivalent of five full I bands (Figure 7I, arrow)Figure 4A2). In either case, the nascent attachments
never develop into an ordered array of recognizable are often visible across the width of each quadrant.
The staggered, overlapping organization of muscle cellsdense bodies and M lines. In contrast, in 530 min wild-
type embryos, an ordered array is already apparent (Fig- within each quadrant results in an uninterrupted pattern
of A bands and I bands along the entire quadrant length.ure 4A2; Figure 4D of [13]). CH1-deleted PAT-6::YFP
also fails to rescue the recruitment of UNC-89 (Figure We conclude that although CH1-deleted PAT-6/acto-
paxin enters nascent muscle attachments in pat-6(s561)7B), myosin A (Figure 7D), or actin filaments (Figure 7F)
to the basal cell membrane. In each muscle quadrant, mutants, it rescues neither attachment patterning nor
the recruitment of potential PAT-6/actopaxin bindinganti-UNC-89 stains a series of large, abnormal clumps
(Figure 7B), just as we observe in pat-6(st561) embryos partners that are downstream from PAT-6/actopaxin in
either the M line or dense body assembly dependencethat are not expressing CH1-deleted PAT-6::YFP (Figure
4A6). Antibodies to myosin A or to F-actin reveal two pathways.
irregular, parallel lines of staining per muscle quadrant,
whether (Figures 7D and 7F) or not (Figures 7H and 7J) Discussion
the embryo is also expressing CH-deleted PAT-6::YFP.
Each line corresponds to one of the two adjacent rows We show that pat-6 encodes the sole actopaxin homo-
log in C. elegans and that a protein null allele of pat-6of muscle cells that comprise each muscle quadrant
and are positioned correctly in the developing body wall. blocks the formation of body wall muscle attachments.
These data demonstrate that PAT-6/actopaxin plays aThe anti-myosin A staining reveals one or perhaps sev-
eral irregular aggregates of myosin filaments that extend critical role during the assembly of focal adhesion homo-
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Our data also show that PAT-6/actopaxin plays an
important role in the spatial patterning of attachments
within the basal sarcolemma. This function may be an
indirect downstream consequence of PAT-6/actopax-
in’s role in linking the attachments to myofilaments. Al-
ternatively, PAT-6/actopaxin may play a direct role in
patterning the attachments.
pat-6 loss-of-function mutations block muscle attach-
ment assembly immediately downstream from pat-4 and
unc-112 loss-of-function mutations, raising the possibil-
ity that PAT-6/actopaxin, UNC-112, and PAT-4/ILK
might work together as part of a multiprotein complex.
Our yeast two- and three-hybrid data support this no-
tion. The kinase domain of PAT-4/ILK binds to the sec-
ond CH domain PAT-6/actopaxin, and we have shown
previously that the PAT-4/ILK kinase domain also binds
the novel FERM domain protein UNC-112 [12]. In yeast
three-hybrid experiments, PAT-4/ILK can bind PAT-6/
actopaxin and UNC-112 simultaneously, forming a ter-
nary complex. It should be noted that UNC-97/PINCH
might be the fourth member of this complex, as we have
confirmed previously that PAT-4/ILK can also bind UNC-
97/PINCH [12]. Consistent with this possibility, it has
recently been reported that mammalian actopaxin/
-parvin/CH-ILKBP coprecipitates with ILK and PINCH
[22] from cell lysates.
PAT-6/actopaxin remains unassembled and easily de-
tectable within the muscle cell cytoplasm in unc-52 and
pat-3 mutants, but is difficult to detect in unc-112 mu-
tants and is not detectable in pat-4 mutants. There are
a number of possible explanations for these results, and
Figure 7. CH1-Deleted PAT-6/Actopaxin in pat-6(st561) Embryos one intriguing possibility is that PAT-6/actopaxin must
(A–F) pat-6(st561) embryos expressing CH1-deleted PAT-6::YFP. (A, enter into a complex with PAT-4/ILK and UNC-112 to
C, and E) YFP channel showing localization of CH1-deleted PAT- avoid degradation within the muscle cell cytoplasm.
6::YFP to muscle attachments (arrows). (B, D, and F) corresponding
We have shown directly by removing PAT-4/ILK viaimmunofluorescence images showing (B) UNC-89, (D) myosin A,
mutation that PAT-6/actopaxin is dependent uponand (F) actin filaments in discontinuous clumps (arrows) along the
PAT-4/ILK for its assembly into attachment complexeslength of a dorsal body wall muscle quadrant.
(G–J) Control immunofluorescence staining of (G and I) wild-type in vivo. This dependence has been suggested previously
and (H and J) nontransformed pat-6(st561) embryos. Myosin A is by the failed recruitment of CH2-deleted forms of acto-
localized in A bands in wild-type (G, arrow), but remains disorga- paxin to focal adhesions [17, 18, 20]. Interestingly, it has
nized in pat-6(st561) (H, arrow). Actin filaments are in I bands in
also been reported that mammalian actopaxin familywild-type (I, arrow), but remain disorganized in pat-6(st561) (J). Ar-
must bind to paxillin to enter focal adhesions [15, 20].rowheads in (B), (D), (F), and (G)–(J) indicate hypodermal cell junc-
We have no data that directly address this issue, buttions stained with monoclonal antibody MH27. Scale bar (A), 5 m.
note that a proper paxillin homolog has not been identi-
fied in C. elegans despite the completed genomic DNAlogs in vivo. We performed a genetic epistasis analysis
sequence [23].of muscle attachment assembly to more clearly define
We have shown directly by removing PAT-6/actopaxinthe role of PAT-6/actopaxin (Figure 1). PAT-6/actopaxin
via mutation that neither PAT-4/ILK nor UNC-112 re-is required to properly recruit actin filaments to the na-
quires an interaction with PAT-6/actopaxin to enter na-scent dense bodies and to recruit UNC-89 and myosin
scent muscle attachments in vivo. Interestingly, this re-filaments to nascent M lines. These are events that occur
sult is inconsistent with a recent report that mammalianlate in the assembly dependence pathways and involve
ILK must bind to actopaxin/-parvin/CH-ILKBP to bemembrane-distal components. Our epistasis analysis
recruited to focal adhesions [22]. This inconsistencyalso shows that several early steps during muscle at-
could reflect differences between C. elegans and mam-tachment formation do not require PAT-6/actopaxin.
malian attachments. It should be noted, however, thatPAT-6/actopaxin is not needed for the initial deposition
the conclusion drawn from the mammalian study isof UNC-52/perlecan in the basal lamina, for integrin to
based upon correlated failures of
186–125 ILK (deletionaccumulate at the basal sarcolemma and enter foci,
of 30 amino acids within the 5 end of the kinase domain)nor for the subsequent recruitment of the attachment
to be recruited to focal adhesions and to bind to acto-proteins UNC-112, PAT-4/ILK, and DEB-1/vinculin to
paxin/-parvin/CH-ILKBP in vitro. Because the 
186–these nascent attachments. Taken together, we con-
125 mutation might also disrupt binding between ILKclude that PAT-6/actopaxin is not required to initiate
and another attachment protein, for example, a mamma-attachment formation but instead is required for later
events that establish linkages to myofilaments. lian homolog of UNC-112, it might be the loss of this
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